Moderna (MRNA) closed the most recent trading day at $99.99, moving -0.24% from the previous trading session.
Moderna (NASDAQ: MRNA) has become a well-known name in healthcare over the past few years thanks to its COVID-19 vaccine. Moderna has very high hopes, but are they too good to be true? To say Moderna has an aggressive growth plan would be an understatement.
Sanofi is all in on AI and thinks it could help alleviate patent timeline pressures from the Inflation Reduction Act.